| Literature DB >> 28456667 |
Wasun Chantratita1, Keum-Soo Song2, Satish Balasaheb Nimse3, Viroj Pongthanapisith4, Nipa Thongbaiphet5, Garanyuta Wongtabtim6, Ekawat Pasomsub7, Kanokwan Angkanavin8, Mukesh Digambar Sonawane9, Shrikant Dasharath Warkad10, Taisun Kim11.
Abstract
According to EASL guidelines and WHO recommendations, the accurate detection of HCV genotypes such as HCV 1a, HCV1b, HCV 2, HCV 3, HCV 4, and HCV 6 (6a, 6f, 6i, 6n) is crucial for the efficient treatment of hepatitis C. HCV Genotyping 9G test allows simultaneous genotyping of HCV 1a, 1b, 2, 3, 4, and 6 (6a, 6f, 6i, and 6n) in clinical samples in 30min. The performance of the test was evaluated by comparison with sequence analysis. Serum samples (n=152) from HCV-infected patients (n=110) and healthy individuals (n=42) were processed under blinded codes. The k coefficient (kappa) values indicated high agreement between the HCV Genotyping 9G test and sequencing. The sensitivity and specificity of the test were 99.1% and 99.7%, respectively. The results indicate that HCV Genotyping 9G test is rapid, reliable, sensitive, and accurate for screening and genotyping of HCV in the clinical specimens.Entities:
Keywords: HCV; HCV-Genotyping; Hepatitis C; Liver cirrhosis; Sequencing
Mesh:
Substances:
Year: 2017 PMID: 28456667 DOI: 10.1016/j.jviromet.2017.04.017
Source DB: PubMed Journal: J Virol Methods ISSN: 0166-0934 Impact factor: 2.014